Cargando…

Does antibiotic treatment duration affect the outcomes of exacerbations of asthma and COPD? A systematic review

Asthma and chronic obstructive pulmonary disease (COPD) cause significant morbidity and mortality worldwide, primarily through exacerbations. Exacerbations are often treated with antibiotics but their optimal course duration is uncertain. Reducing antibiotic duration may influence antimicrobial resi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stolbrink, Marie, Amiry, Jack, Blakey, John D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100164/ https://www.ncbi.nlm.nih.gov/pubmed/29232988 http://dx.doi.org/10.1177/1479972317745734

Ejemplares similares

Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis
por: Stolbrink, Marie, et al.
Publicado: (2019)

Predictors of repeated acute hospital attendance for asthma in children: A systematic review and meta‐analysis
por: Ardura‐Garcia, Cristina, et al.
Publicado: (2018)

Amoxicillin is associated with a lower risk of further antibiotic prescriptions for lower respiratory tract infections in primary care – A database analysis spanning over 30 years
por: Stolbrink, Marie, et al.
Publicado: (2018)

The use of antibiotics in treatment of acute COPD exacerbations does not adhere to national guidelines
por: Nielsen, Hanne, et al.
Publicado: (2010)

Use of Antibiotics for Exacerbations of COPD
por: Daniels, Johannes M.A., et al.
Publicado: (2017)

A systematic review of methodology used in the development of prediction models for future asthma exacerbation
por: Bridge, Joshua, et al.
Publicado: (2020)

Rhinovirus-Induced Exacerbations of Asthma and COPD
por: Hershenson, Marc B.
Publicado: (2013)

Virus-induced exacerbations in asthma and COPD
por: Kurai, Daisuke, et al.
Publicado: (2013)

Viral-associated exacerbations of asthma and COPD
por: Traves, Suzanne L, et al.
Publicado: (2007)

The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials
por: Eriksson, Göran, et al.
Publicado: (2017)

Antibiotics used in the ambulatory management of acute COPD exacerbations
por: Beauchesne, Marie-France, et al.
Publicado: (2008)

Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study
por: Dal Negro, Roberto W., et al.
Publicado: (2017)

Optimizing antibiotic selection in treating COPD exacerbations
por: Siddiqi, Attiya, et al.
Publicado: (2008)

Emergency department antibiotic use for exacerbations of COPD
por: Tichter, Aleksandr M, et al.
Publicado: (2018)

Does pay-for-performance improve patient outcomes in acute exacerbation of COPD admissions?
por: Stone, Philip W, et al.
Publicado: (2022)

Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit
por: López-Campos, Jose Luis, et al.
Publicado: (2015)

Noninvasive ventilation duration as an outcome predictor in acute exacerbation of COPD and respiratory failure: The saga continues
por: Karim, Habib Md Reazaul, et al.
Publicado: (2021)

The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review
por: Stolbrink, Marie, et al.
Publicado: (2022)

Blood miRNAs Are Linked to Frequent Asthma Exacerbations in Childhood Asthma and Adult COPD
por: Tiwari, Anshul, et al.
Publicado: (2022)

Duration of noninvasive ventilation is not a predictor of clinical outcomes in patients with acute exacerbation of COPD and respiratory failure
por: Ghazala, Laith, et al.
Publicado: (2021)

Acute exacerbations of COPD and risk of lung cancer in COPD patients with and without a history of asthma
por: Gagnat, Ane Aamli, et al.
Publicado: (2020)

Revisiting the Use of Antibiotics to Prevent COPD Exacerbation: Is Doxycycline the Answer?
por: Adrish, Muhammad, et al.
Publicado: (2023)

Strategies for improving outcomes of COPD exacerbations
por: Wilkinson, Tom, et al.
Publicado: (2006)

Predictors of exacerbations of asthma and COPD during one year in primary care
por: Al-ani, Salwan, et al.
Publicado: (2013)

Occupational exposures and exacerbations of asthma and COPD—A general population study
por: Skaaby, Stinna, et al.
Publicado: (2020)

Consolidation and Exacerbation of COPD
por: Hurst, John R.
Publicado: (2018)

The association between sleep duration, respiratory symptoms, asthma, and COPD in adults
por: Ruan, Zhishen, et al.
Publicado: (2023)

Impact of Clinical Factors on Generic and Disease-Specific Quality of Life in COPD and Asthma-COPD Overlap with Exacerbations
por: Lázár, Zsófia, et al.
Publicado: (2020)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
por: Mathioudakis, Alexander G., et al.
Publicado: (2017)

Respiratory Infections Cause the Release of Extracellular Vesicles: Implications in Exacerbation of Asthma/COPD
por: Eltom, Suffwan, et al.
Publicado: (2014)

When should acute exacerbations of COPD be treated with systemic corticosteroids and antibiotics in primary care: a systematic review of current COPD guidelines
por: Laue, Johanna, et al.
Publicado: (2015)

Criteria of prescription of antibiotics and systemic corticosteroids among pulmonologists and general practictioners during asthma and COPD exacerbations: a southern Italian survey
por: Dragonieri, Silvano, et al.
Publicado: (2021)

Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis
por: Hoult, George, et al.
Publicado: (2022)

A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations
por: Mathioudakis, Alexander G., et al.
Publicado: (2019)

Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations?
por: Adepoju, Victor A.
Publicado: (2019)

Effects of Pre-Hospital Dexamethasone Administration on Outcomes of Patients with COPD and Asthma Exacerbation; a Cross-Sectional Study
por: Huabbangyang, Thongpitak, et al.
Publicado: (2023)

COPD Exacerbation-Related Pathogens and Previous COPD Treatment
por: Sim, Yun Su, et al.
Publicado: (2022)

Effects of Pleuran (Β–Glucan from Pleurotus Ostreatus) Supplementation on Incidence and Duration of COPD Exacerbations
por: Minov, Jordan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_usv3ebgth8t93mpvq0eod59202